The forecasted cardiovascular system medicine sales in Denmark from 2024 to 2028 indicate a declining trend. In 2024, the sales are expected to account for 3% of total sales, decreasing to 1.6% by 2028. This represents a year-on-year decline, with percentages dropping by 13.3% from 2024 to 2025, 11.5% from 2025 to 2026, 17.4% from 2026 to 2027, and 15.8% from 2027 to 2028. The compound annual growth rate (CAGR) over the five-year period shows an average decline of 14.1% per year.
Future trends to watch for include the potential impact of new medical technologies and treatments, shifts in healthcare policies, aging population dynamics, and changes in patient behavior towards preventive cardiovascular care. Additionally, the development of innovative drugs and personalized medicine could influence future sales in unexpected ways.
